Evidence map›Paper›PMID 34967686›Full record

ReviewJournal of aerosol medicine and pulmonary drug delivery2022

Inhaled Delivery of Anti-Pseudomonal Phages to Tackle Respiratory Infections Caused by Superbugs.

Hak-Kim Chan, Rachel Yoon Kyung Chang

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of aerosol medicine and pulmonary drug delivery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Phage therapy: breathing new tactics into lower respiratory tract infection treatments.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hak-Kim ChanAdvanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-7054-3137
Rachel Yoon Kyung ChangAdvanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
The University of Sydney · AU

Funding

Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approachR33AI121627 · NIAID · UNIVERSITY OF SYDNEY · PI CHAN, KIM · 2018 to 2020
$598k
Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approachR21AI121627 · NIAID · UNIVERSITY OF SYDNEY · PI CHAN, KIM · 2016 to 2017
$287k
NIAID NIH HHS R21 AI121627NIAID NIH HHS R33 AI121627
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BacteriophagesRespiratory Tract InfectionsAdministration, InhalationAerosolsAnimalsDry Powder InhalersMiceParticle SizePowdersPseudomonas aeruginosaAerosolsPowdersinhaled bacteriophage therapyliquid formulationpowder formulationrespiratory infectionsuperbugs

Identifiers

PMID34967686
PMCPMC8982117
OpenAlexW4200445640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.